• Cesca Therapeutics’ Chief Technology Officer, Phil Coelho, Provides Deep Dive into the CAR-T Manufacturing Process in Cell & Gene Therapy

    المصدر: Nasdaq GlobeNewswire / 23 مايو 2018 05:30:45   America/Los_Angeles

    N/A
شارك على،